Sanaa Khalil

Humoral Immune Response Against Survivin in Patients with Lung Cancer: Evaluation of the Humoral Immune Response Against Survivin in Patients with Lung Cancer Sanaa Khalil

This Book is presenting the Evaluation of the humoral immune response against survivin in patients with lung, Serum samples from 33 small cell lung cancer (SCLC) and 117 non-small cell lung cancer (NSCLC) patients upon diagnosis, and from 100 controls, were tested by ELISA for anti-survivin antibodies. We conclude that survivin does not induce considerable humoral responses in lung cancer. Potentially, however, strong anti-survivin antibody responses can be elicited during the follow-up of the patients, whose clinical significance remains to be elucidated. These findings, together with our previous data concerning survivin expression and the related cytolytic T cell responses in lung cancer, signify a high tolerogenic potential of this tumor-associated antigen.